Week of Dec 8 2017 Weekly Recap & The Week Ahead

“I’m always thinking about losing money as opposed to making money. Don’t focus on making money, focus on protecting what you have” – Paul Tudor Jones

1. Walgreens Rebranding Effort in Pharmacy Wars — Walgreens is taking a different approach to grow in the wake of CVS Health (NYSE:CVS) announcing plans to acquire Aetna (NYSE:AET). The company is re-positioning to reach two demographics of female shoppers – millennials and Gen X – with a big emphasis on beauty and food products.
2. Japan Wants Missiles that Could Strike N.Korea — Reuters reported Japan is preparing to acquire precision air-launched missiles that for the first time would give it the capability to strike North Korea. The country is exploring Lockheed Martin’s (NYSE:LMT) JASSM-ER, as well as missiles from Norway’s Kongsberg Defence & Aerospace. The report comes as UN chief diplomat Jeffrey Feltman travels to Pyongyang for rare, high-level, political talks to diffuse tension.
3. The Senate and House Passed the “Tax Cuts and Jobs Act Bill ” — the Senate and House lawmakers passed the “Tax Bill” and are now working to come up with a final version of the tax bill, and they still have some differences to resolve. Below is the summary of the Senate and House versions.

4. House Approves Two-Week Funding Extension, Avoiding Government Shutdown — the Senate has passed a stop-gap spending measure to continue funding the federal government for two weeks. President Trump would sign a stop-gap spending measure funding the government through Dec. 22, according to a statement from the White House. In addition, the White House said it will move forward with a massive infrastructure program in 2018.

The week ahead — Economic data from Econoday.com:

Leave a Reply

You must be logged in to post a comment.

Search
Calendar
December 2017
M T W T F S S
« Nov   Jan »
 123
45678910
11121314151617
18192021222324
25262728293031
Archives
Categories
The information provided by The EGS Blog is based on sources believed to be reliable, but it is not guaranteed to be accurate. There is no guarantee that the recommendations of The EGS Blog will be profitable or will not be subject to losses. The information provided by The EGS Blog is not a recommendation or a solicitation that any particular investor should purchase or sell any particular security in any amount, or at all. The investments discussed or recommended herein may be unsuitable for investors depending on their specific investment objectives and financial position. At any time EGS LLC and its principals may maintain positions that are contrary to positions announced within the subscription service. In no event will The EGS Blog be liable to you or anyone else for any incidental, consequential, special, or indirect damage (including but not limited to lost profits or trading losses). PAST PERFORMANCE IS NO GUARANTEE OF FUTURE RESULTS

© Copyright 2024 Market Outlook All Rights Reserved
Design by EGS Sponsored by Equity Guidance LLC